Skip to content
CompanySight
Company No. 10309997 · Incorporated 3 Aug 2016

Spark Therapeutics UK Ltd

Registered name: SPARK THERAPEUTICS UK LTD

Part of Spark Therapeutics International Holdings, Inc group

Spark Therapeutics UK Ltd made £2.1m revenue and a £36.3k loss in the year to 31 Dec 2025.

Spark Therapeutics UK Ltd’s revenue fell 4% to £2.1m in the year to 31 Dec 2025, with a loss of £36.3k and 2 employees. The company is classified under “other human health activities” and is based in Welwyn Garden City; we hold 4 years of its filed accounts.

Full P&L filedSection Q · Human health and social workSIC 86900Other human health activities
Status
Active
Location
Welwyn Garden City, East of England
Age
10 yrs · since 2016
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Small team
Revenue
£2.1m
Growth ▼3.5%
Profit
−£36.3k
Growth —
Profit margin
−1.7%
 
Employees
2
Change ▼33.3%
Profit / employee
−£18.1k
Revenue/employee £1m
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 202331 Dec 202431 Dec 2025
DisclosureFull P&LFull P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)£803k£1.4m£2.2m£2.1m
Operating profit£62.9k£132k£147k−£11.6k
Profit before tax£522k−£86.5k£112k−£1.5k
Profit after tax£409k−£64.9k−£61.3k−£36.3k
Profit (best available)£409k−£64.9k−£61.3k−£36.3k
Employees (average)3332
Ratios
Profit margin50.9%−4.5%−2.8%−1.7%
Revenue per employee£268k£476k£721k£1m
Profit per employee£136k−£21.6k−£20.4k−£18.1k
Growth (year on year)
Revenue growth—▲77.6%▲51.7%▼3.5%
Profit growth—▼115.9%——
Headcount growth—0%0%▼33.3%
Balance sheet — indirect signals, not revenue
Cash at bank£373k£90.7k——
Net assets£4.5m£4.5m——
Current assets£4.7m£4.5m——
Debtors£2.9k£0——
SourceFullAccounts · bulk data Oct 2024FullAccounts · bulk data Oct 2024Accounts · bulk data Oct 2026Accounts · bulk data Oct 2026
Derived from the latest filing

How the business works

Profit margin
−1.7%
Profit ÷ revenue.
Gross margin
—
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£1m
Revenue ÷ average employees.
Profit per employee
−£18.1k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now —
Cash at bank
—
Now —
Headcount
▼33%
Now 2
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Spark Therapeutics International Holdings, Inc (registered outside the UK register)ultimate parent75–100%
  2. Spark Therapeutics UK Ltdthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from accounts for the year to 31 Dec 2025 (profit −£36.3k), from the Companies House accounts bulk data published Oct 2026. Spotted an error? Request a correction.

Updated from Companies House on 17 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.